The Latest Breaking News from Sanofi

With the advent of advanced medications and the increasing need for personalized treatments, the pharmaceutical industry looks well-poised for long-term growth. Therefore, it could be worth looking into three fundamentally sound pharma stocks, Pfizer (PFE), Sanofi (SNY), and GSK plc (GSK), that are offering significant value. Read more….

U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year

StemCures, a medical clinic in Ohio focused on stem cell therapy, will be establishing a manufacturing lab in Telangana with around $54 million investment and employment potential for around 150 people.

'Innovation is powered by more than just money,' writes Sanofi CEO Paul Hudson.

Paris (AFP) - French pharmaceutical giant Sanofi announced trial results on Friday that showed its preventative treatment for respiratory syncytial virus (RSV) reduced the rate of babies being hospitalised by more than 80 percent.

Sanofi said Friday its shot significantly reduced the risk of babies becoming hospitalized with RSV. But Sanofi stock dipped Friday.

If invited, you will receive a booster dose of a Covid-19 vaccine made by Pfizer, Moderna, or Sanofi

The University of Edinburgh’s Neil Mabbott on the vaccine technology being used for Covid booster jabs from this month.

The vaccine being used in the Spring booster campaign works in a different way to previous jabs